Search Count: 45
 |
Cryoem Structure Of Compound Hnc-1664 Bound With Rdrp-Rna Complex Of Sars-Cov-2
Organism: Severe acute respiratory syndrome coronavirus 2, Severe acute respiratory syndrome coronavirus, Synthetic construct
Method: ELECTRON MICROSCOPY Release Date: 2024-12-04 Classification: VIRAL PROTEIN/RNA Ligands: A1LVZ, MG |
 |
Cryo-Em Structure Of Lassa Virus Rdrp Elongation Complex With The Ntp Form Of Compound Hnc-1664 Bound In The Active Site
Organism: Lassa virus josiah, Synthetic construct
Method: ELECTRON MICROSCOPY Release Date: 2024-12-04 Classification: REPLICATION Ligands: A1LVZ |
 |
Crystal Structure Of The Enterovirus 71 Rdrp Elongation Complex With The Nucleoside Monophosphate Form Of Compound Hnc-1664 At Product Position -1 (Post-Translocation State)
Organism: Enterovirus a71, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:3.00 Å Release Date: 2024-12-04 Classification: REPLICATION Ligands: ZN |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2024-02-07 Classification: HYDROLASE Ligands: MG, X5W |
 |
Crystal Structure Of Bont/E Receptor Binding Domain In Complex With Sv2 And Vhh
Organism: Vicugna pacos, Homo sapiens, Clostridium botulinum
Method: X-RAY DIFFRACTION Resolution:2.59 Å Release Date: 2023-04-05 Classification: TOXIN Ligands: NAG, SO4, PEG |
 |
Crystal Structure Of Bont/E Receptor Binding Domain In Complex With Sv2, Vhh, And Sialic Acid
Organism: Vicugna pacos, Homo sapiens, Clostridium botulinum
Method: X-RAY DIFFRACTION Resolution:2.77 Å Release Date: 2023-04-05 Classification: TOXIN Ligands: NAG, SO4, PG4, SLB |
 |
Organism: Vicugna pacos, Clostridium botulinum
Method: X-RAY DIFFRACTION Resolution:3.23 Å Release Date: 2023-04-05 Classification: ANTITOXIN/TOXIN |
 |
C-Terminal Bromodomain Of Human Brd2 With 1,5-Dimethyl-N-(2-(Methylamino)-2-Oxo-1-(Tetrahydro-2H-Pyran-4-Yl)Ethyl)-6-Oxo-N-(2-Phenyl-2-(Pyridin-2-Yl)Ethyl)-1,6-Dihydropyridine-3-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.41 Å Release Date: 2021-10-13 Classification: NUCLEAR PROTEIN Ligands: 80Z, EDO, PE4 |
 |
C-Terminal Bromodomain Of Human Brd4 N-(2,2-Diphenylethyl)-4-Methoxy-3,5-Dimethyl-N-(2-(Methylamino)-2-Oxoethyl)Benzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.51 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: V9Z |
 |
C-Terminal Bromodomain Of Human Brd2 With 5-(1-(1,3-Dimethoxypropan-2-Yl)-5-Morpholino-1H-Benzo[D]Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, PE4, NV2 |
 |
C-Terminal Bromodomain Of Human Brd2 With N-(2,2-Diphenylethyl)-1,5-Dimethyl-N-(2-(Methylamino)-2-Oxoethyl)-6-Oxo-1,6-Dihydropyridine-3-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: VBH, EDO |
 |
C-Terminal Bromodomain Of Human Brd2 With 1,5-Dimethyl-N-(2-(Methylamino)-2-Oxoethyl)-6-Oxo-N-(2-Phenylpropyl)-1,6-Dihydropyridine-3-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, PE4, VBE |
 |
N-Terminal Bromodomain Of Human Brd2 With 5-(4-(4-Fluorophenyl)-1H-Imidazol-5-Yl)-1-Methylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.26 Å Release Date: 2020-02-19 Classification: TRANSCRIPTION Ligands: SO4, NUQ, EDO |
 |
N-Terminal Bromodomain Of Human Brd4 With 1-((1-Acetylpiperidin-4-Yl)Methyl)-2-(4-Hydroxy-3,5-Dimethylphenyl)-N-Methyl-1H-Benzo[D]Imidazole-5-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.48 Å Release Date: 2020-01-15 Classification: TRANSCRIPTION Ligands: NUW, EDO |
 |
N-Terminal Bromodomain Of Human Brd4 With 1,3-Dimethyl-5-(1-((Tetrahydro-2H-Pyran-4-Yl)Methyl)-1H-Benzo[D]Imidazol-2-Yl)Pyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2020-01-15 Classification: TRANSCRIPTION Ligands: EDO, NUB |
 |
N-Terminal Bromodomain Of Human Brd4 With 5-(1-(1,3-Dimethoxypropan-2-Yl)-5-Morpholino-1H-Benzo[D]Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2020-01-15 Classification: TRANSCRIPTION Ligands: EDO, NV2 |
 |
N-Terminal Bromodomain Of Human Brd4 With 5-(1-(1,3-Dimethoxypropan-2-Yl)-5-Morpholino-1H-Benzo[D]Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2020-01-15 Classification: TRANSCRIPTION Ligands: SO4, NUH, EDO |
 |
Organism: Clostridium botulinum e1 str. 'bont e beluga'
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2017-10-25 Classification: UNKNOWN FUNCTION |
 |
Computationally Designed Inhibitor Peptide Hb1.6928.2.3 In Complex With Influenza Hemagglutinin (A/Puertorico/8/1934)
Organism: Influenza a virus (strain a/puerto rico/8/1934 h1n1), Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2017-09-27 Classification: VIRAL PROTEIN/DE NOVO PROTEIN Ligands: NAG, PGF, PEG |
 |
Receptor Binding Domain Of Bont/B In Complex With Mini-Protein Binder Bot.0671.2
Organism: Clostridium botulinum, Unidentified
Method: X-RAY DIFFRACTION Resolution:2.75 Å Release Date: 2017-09-20 Classification: TOXIN |